News
Colorectal adenocarcinoma incidence is decreasing overall but increasing among individuals aged 15 to 34 years, with an APC of 1.75. Pancreatic adenocarcinoma incidence is rising across all age ...
Colorectal adenocarcinoma diagnoses also have increased among patients aged 15 to ... Individuals aged 55 years and older also had the highest number of colorectal cancer diagnoses (n = 976,716 ...
In combination with Roche’s PD-L1 blocker Tecentriq, zanzalintinib bested Bayer’s Stivarga. Exelixis is positioning the drug candidate as a successor to cabozantinib, which is set to lose patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results